FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/086042 [Registered on: 30/04/2025] Trial Registered Prospectively
Last Modified On: 30/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Reducing the menstrual pain by herbal formulation 
Scientific Title of Study   An Exploratory Study to evaluate the effect of Chaturbeeja Arka in reducing the pain in Primary Dysmenorrhea 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Deepu Rani 
Designation  PG scholar 
Affiliation  Amrita school of Ayurveda  
Address  Amrita school of Ayurveda AMRITA AYURVEDA HOSPITAL,Prasuti tantra and stir yoga department OPD department Room no. 8 clappana vallikavu kollam kerala

Kollam
KERALA
690525
India 
Phone  9756900088  
Fax    
Email  deepu.rani23@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR.Hemavathi S.K 
Designation  HOD Prasuti tantra and stri roga d 
Affiliation  Amrita school of Ayurveda  
Address  Amrita school of Ayurveda clappana vallikavu kollam kerala

Kollam
KERALA
690525
India 
Phone  9446962291  
Fax    
Email  hemavathi@ay.amrita.edu  
 
Details of Contact Person
Public Query
 
Name  Deepu Rani 
Designation  PG scholar 
Affiliation  Amrita school of Ayurveda  
Address  Amrita school of Ayurveda AMRITA AYURVEDA HOSPITAL,Prasuti tantra and stir roga,OPD No. 8 clappana vallikavu kollam kerala

Kollam
KERALA
690525
India 
Phone  9756900088  
Fax    
Email  deepu.rani23@gmail.com  
 
Source of Monetary or Material Support  
Amrita ayurveda hospital Amrita school of ayurveda,Prasuti tantra and stri roga department opd room no 8,clappana Kollam Kerala 
 
Primary Sponsor  
Name  OTHER 
Address  Amrita school of ayurveda, Amrita ayurveda hospital,Prasuti tantra and stri roga department OPD NO.8 clappana vallikavu kollam kerala 690525 INDIA 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Deepu Rani  Amrita Ayurveda Hospital,Amrita school of ayurveda  Prasuti tantra and stri roga department opd room no 8 clappana vallikavu kollam Kerala 690525
Kollam
KERALA 
9756900088

deepu.rani23@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Amrita School of Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N944||Primary dysmenorrhea. Ayurveda Condition: UDAVARTINI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Chaturbeeja arka, Reference: ARKA PRAKASH BOOK by LANKAPATI RAVANA, Route: Oral, Dosage Form: Arka, Dose: 10(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 3 Days, anupAna/sahapAna: Yes(details: -Equal quantity of water), Additional Information: -IN book ARKA PRAKASH by LANKAPATI RAVANA in chaturth shatak shloka 12 there is direct reference of Chaturbeeja arka
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  25.00 Year(s)
Gender  Female 
Details  Regular menstrual cycles for three consecutive months having moderate to severe Primary Dysmenorrhea maintaining menstrual history diary or records.Those who have video calling facility on their mobile. 
 
ExclusionCriteria 
Details  Participants with genitourinary infection, under hormonal therapy, diagnosed case of pelvic pathology, Plan for conception 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Reduction in intensity of pain using the vas scale.  First three days of menstruation
for one menstrual cycle. 
 
Secondary Outcome  
Outcome  TimePoints 
Reduction in duration of pain and improvement in quality of life using CMSS and VMSS scale respectively  first three days of menstruation cycle twice daily using video calls  
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   20/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="7"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Primary Dysmenorrhea is a most common disorder that affects upto 70% of the female population. It affects patients with significant impairment in quality of life, sleep,and work performance because of pain. The prevalence of Primary Dysmenorrhea has increased in recent decades due to sedentary lifestyle and unhealthy food habits. Primary Dysmenorrhea can be compared with Udavartini in Ayurveda,which is one of the diseases caused by vitiation of vata and can be treated with vata anulomana drugs. In the proposed research,a short term and more palatable drug approach will be used to treat primary dysmenorrhea. This study aims to assess the effectiveness of interventions with internally administered herbal formulations for better outcomes in the treatment of primary dysmenorrhea.
The study is an exploratory study. A total of 40 patients fulfilling the inclusion criteria will be selected. The treatment protocol comprised Chaturbeeja arka 10 ml  for first three days of menstruation twice orally with equal quantity of water for one menstruation cycle. Patients will be assessed based on Vas score,Cox menstrual symptom scale and VMSS scale. The data will be statistically evaluated with friedman test.
 
Close